The use of questionnaires for measuring patient‐reported side effects of drugs: its importance and methodological challenges
- 25 February 2008
- journal article
- perspective
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 17 (3) , 278-296
Abstract
Patient‐reported outcomes such as Quality of Life often play an important part in the efficacy assessment of drug treatment. Although instruments that measure quality of life can detect the positive effects of treatments on health status, they may not measure the effect of negative treatment‐related symptoms. Patients often fail to spontaneously report common or clinically mild drug‐related symptoms, even though the same symptoms can result in the stopping or skipping of prescribed doses. Therefore, as with quality of life assessments, the perception of patients on possible side effects of treatments is best captured by the use of self‐report questionnaires. There are substantial challenges with creating well‐validated, relevant questionnaires that capture the full range of patient‐reported symptoms and signs. A review of 13 existing instruments showed that many patient‐rated side effect questionnaires had been developed, often to a high standard, using well‐established psychometric methods. However, there were some inconsistencies in the methods used by the questionnaire developers, indicating the need for standardisation when creating new, or adapting previous, instruments. Even with their current deficits, it is important that patient‐reported side effect questionnaires be used more in drug development, health outcomes research and resource allocation; all with the ultimate aim of improving quality of patient care. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 56 references indexed in Scilit:
- Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ, 2004
- Psychometric Evaluation of Two Scales Assessing Functional Status and Peripheral Neuropathy Associated With Chemotherapy for Ovarian Cancer: A Gynecologic Oncology Group StudyOncology Nursing Forum, 2004
- Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapyInternational Journal of Gynecological Cancer, 2003
- UKU-SERS-Pat - the UKU side effect self-rating scaleEuropean Psychiatry, 2002
- How do patients' treatment preferences compare with those of clinicians?Quality and Safety in Health Care, 2001
- Women's knowledge of, and attitudes to, contraceptive effectiveness and adverse health effectsBMJ Sexual & Reproductive Health, 2000
- Side effect profile and adherence to in the treatment of Multiple Sclerosis with interferon beta-laMultiple Sclerosis Journal, 1998
- Psychometric evaluation of a squestionnaire to document side‐effects of chemotherapyJournal of Advanced Nursing, 1997
- Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatmentsEpilepsy Research, 1996
- Development and validation of brief measures of positive and negative affect: The PANAS scales.Journal of Personality and Social Psychology, 1988